Sintx Technologies awarded patent for silicon nitride biomaterial applications

Sintx Technologies (SINT) has achieved a significant milestone. The United States Patent and Trademark Office has issued a Notice of Allowance for Sintx’s patent application no. 17/237,687, titled “Methods of Silicon Nitride Laser Cladding.” This milestone underscores Sintx’s leadership in biomaterial innovation and reinforces its robust intellectual property portfolio. The patent, expected to be issued soon, protects a revolutionary method for laser bonding bioactive silicon nitride to various biomedical implant substrates, including titanium, alumina, zirconia, and advanced polymers like PEKK. This breakthrough technology enhances the biological performance of these substrates by imparting silicon nitride’s superior osseointegration and bacterial resistance properties.